Fisetin Attenuates Arsenic-Induced Hepatic Damage by Improving Biochemical, Inflammatory, Apoptotic, and Histological Profile: In Vivo and In Silico Approach

Table 3

Depicts levels of inflammatory markers.

Groups	Control	Arsenic	Arsenic + Fisetin	Fisetin
NF-κB (ng/g tissue)	12.53 ± 0.64^a	64.38 ± 0.94^b	17.97 ± 1.00^a	12.16 ± 0.67^a
TNF-α (ng/g tissue)	6.31 ± 0.53^a	17.76 ± 1.02^b	8.73 ± 0.50^a	6.26 ± 0.56^a
IL-1β (ng/g tissue)	23.89 ± 1.13^a	87.38 ± 1.28^b	29.57 ± 1.09^a	23.84 ± 1.01^a
IL-6 (ng/g tissue)	4.62 ± 0.45^a	22.64 ± 2.00^b	7.11 ± 0.98^a	4.59 ± 0.37^a
COX-2 (ng/g tissue)	23.39 ± 0.80^a	65.75 ± 2.19^b	29.10 ± 1.29^a	23.36 ± 0.70^a

Superscripts indicate considerable difference at probability value  < 0.05.